Eisai Shares Outstanding 2006-2020 | ESALY

Eisai shares outstanding history from 2006 to 2020. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
  • Eisai shares outstanding for the quarter ending September 30, 2020 were M, a 100% decline year-over-year.
  • Eisai 2020 shares outstanding were 0.287B, a 0.01% decline from 2019.
  • Eisai 2019 shares outstanding were 0.287B, a 0.18% increase from 2018.
  • Eisai 2018 shares outstanding were 0.286B, a 0.1% decline from 2017.
Eisai Annual Shares Outstanding
(Millions of Shares)
2020 287
2019 287
2018 286
2017 286
2016 286
2015 286
2014 285
2013 285
2012 285
2011 285
2010 285
2009 285
2008 284
2007 285
2006 286
2005 287
Eisai Quarterly Shares Outstanding
(Millions of Shares)
2020-09-30
2020-06-30 287
2019-06-30 286
2018-06-30 286
2017-06-30 286
2016-06-30 286
2015-06-30 286
2015-03-31 286
2014-12-31 285
2014-09-30 285
2014-06-30 285
2014-03-31 285
2013-12-31 285
2013-09-30 285
2013-06-30 285
2013-03-31 285
2012-12-31 285
2012-09-30 286
2012-06-30 285
2012-03-31 284
2011-12-31 285
2011-09-30 284
2011-06-30 285
2011-03-31 280
2010-12-31 285
2010-09-30 285
2010-06-30 285
2010-03-31 285
2009-12-31 285
2009-09-30 285
2009-06-30
2009-03-31 285
2008-12-31 285
2008-09-30 285
2008-06-30 285
2008-03-31 284
2007-12-31 285
2007-09-30 284
2007-06-30 284
2007-03-31 284
2006-12-31 285
2006-09-30 285
2006-06-30 286
2006-03-31 286
2005-12-31 286
2005-09-30 286
2005-06-30 286
2005-03-31 286
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $22.474B $6.400B
Eisai Co LTD is involved in the Biotechnology and Drug Industry. Their principle activities are the manufacture and sale of pharmaceutical products. Operations are carried out through the following divisions: Pharmaceuticals: veterinary drugs other food additives, livestock feed and pharmaceutical production systems and equipment. The Group has overseas consolidated subsidiaries in the United States, Canada, the United Kingdom, France, Germany, East Southeast Asia and South and Central America.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $76.680B 41.80
Takeda Pharmaceutical (TAK) Japan $57.916B 10.81
Astellas Pharma (ALPMY) Japan $30.701B 19.17
Merck (MKGAF) Germany $22.165B 0.00
UCB SA (UCBJF) Belgium $20.763B 0.00
Catalent (CTLT) United States $19.060B 57.01
Grifols, S.A (GRFS) Spain $13.050B 14.94
Neurocrine Biosciences (NBIX) United States $11.155B 87.79
Jazz Pharmaceuticals (JAZZ) Ireland $9.526B 15.39
Ionis Pharmaceuticals (IONS) United States $8.918B 87.37
Arrowhead Pharmaceuticals (ARWR) United States $8.645B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $8.532B 0.00
United Therapeutics (UTHR) United States $7.526B 16.02
IPSEN SA ADR (IPSEY) France $7.292B 0.00
STADA ARZNEIMI (STDAF) Germany $6.884B 0.00
Orion OYJ (ORINY) Finland $6.427B 22.30
Evotec AG (EVTCY) Germany $5.923B 401.50
Sage Therapeutics (SAGE) United States $4.708B 0.00
FibroGen (FGEN) United States $4.513B 0.00
ChemoCentryx (CCXI) United States $4.486B 0.00
PTC Therapeutics (PTCT) United States $4.334B 0.00
Hypermarcas (HYPMY) Brazil $4.187B 16.52
Cronos Group (CRON) Canada $3.526B 0.00
Corcept Therapeutics (CORT) United States $3.318B 32.09
Nektar Therapeutics (NKTR) United States $3.183B 0.00
Pacira BioSciences (PCRX) United States $3.032B 65.85
Taro Pharmaceutical Industries (TARO) Israel $2.938B 15.00
Revolution Medicines (RVMD) United States $2.861B 0.00
Xencor (XNCR) United States $2.796B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $2.371B 0.00
Tilray (TLRY) Canada $2.295B 0.00
USANA Health Sciences (USNA) United States $1.884B 16.58
Translate Bio (TBIO) United States $1.831B 0.00
Endo (ENDP) Ireland $1.677B 2.55
Ironwood Pharmaceuticals (IRWD) United States $1.671B 14.30
Heron Therapeutics (HRTX) United States $1.661B 0.00
BioCryst Pharmaceuticals (BCRX) United States $1.617B 0.00
Ocular Therapeutix (OCUL) United States $1.580B 0.00
ImmunoGen (IMGN) United States $1.505B 0.00
Indivior (INVVY) United States $1.467B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $1.454B 10.10
Trillium Therapeutics (TRIL) Canada $1.324B 0.00
Theravance Biopharma (TBPH) Cayman Islands $1.178B 0.00
Karyopharm Therapeutics (KPTI) United States $1.156B 0.00
Organogenesis Holdings (ORGO) United States $1.122B 0.00
VAXART, INC (VXRT) United States $1.100B 0.00
Zogenix (ZGNX) United States $1.092B 0.00
Radius Health (RDUS) United States $0.990B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.967B 0.00
CLINIGEN GP (CLIGF) United Kingdom $0.942B 0.00
Vectura Group (VEGPF) United Kingdom $0.925B 0.00
Aerie Pharmaceuticals (AERI) United States $0.853B 0.00
Collegium Pharmaceutical (COLL) United States $0.846B 49.92
Esperion Therapeutics (ESPR) United States $0.803B 0.00
Calliditas Therapeutics AB (CALT) Sweden $0.770B 0.00
Aclaris Therapeutics (ACRS) United States $0.757B 0.00
Acutus Medical (AFIB) United States $0.732B 0.00
Ardelyx (ARDX) United States $0.694B 0.00
Chinook Therapeutics (KDNY) United States $0.679B 0.00
Sundial Growers (SNDL) Canada $0.665B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.622B 0.00
Flexion Therapeutics (FLXN) United States $0.603B 0.00
Molecular Templates (MTEM) United States $0.597B 0.00
Spectrum Pharmaceuticals (SPPI) United States $0.572B 0.00
Altimmune (ALT) United States $0.559B 0.00
Akebia Therapeutics (AKBA) United States $0.536B 0.00
Siga Technologies (SIGA) United States $0.532B 14.94
Harpoon Therapeutics (HARP) United States $0.531B 0.00
Jounce Therapeutics (JNCE) United States $0.524B 0.00
PROFOUND MEDICL (PROF) Canada $0.524B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.502B 0.00
Summit Therapeutics (SMMT) United States $0.497B 0.00
DURECT (DRRX) United States $0.486B 0.00
TherapeuticsMD (TXMD) United States $0.483B 0.00
Menlo Therapeutics (VYNE) United States $0.443B 0.00
CASI Pharmaceuticals (CASI) United States $0.429B 0.00
Rafael Holdings (RFL) United States $0.402B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.397B 0.00
Jaguar Animal Health (JAGX) United States $0.392B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.385B 10.03
Innate Pharma SA (IPHYF) France $0.371B 0.00
MEI Pharma (MEIP) United States $0.343B 0.00
Concert Pharmaceuticals (CNCE) United States $0.341B 0.00
Lannett Co Inc (LCI) United States $0.331B 8.71
Matinas Biopharma Holdings (MTNB) United States $0.327B 0.00
Nature's Sunshine Products (NATR) United States $0.314B 20.19
Alpine Immune Sciences (ALPN) United States $0.303B 0.00
Redhill Biopharma (RDHL) Israel $0.296B 0.00
KalVista Pharmaceuticals (KALV) United States $0.295B 0.00
Xeris Pharmaceuticals (XERS) United States $0.274B 0.00
CTI BioPharma (CTIC) United States $0.254B 0.00
Infinity Pharmaceuticals (INFI) United States $0.254B 0.00
IMV INC (IMV) Canada $0.242B 0.00
Otonomy (OTIC) United States $0.233B 0.00
OptiNose (OPTN) United States $0.232B 0.00
Calithera Biosciences (CALA) United States $0.226B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.218B 0.00
Oncternal Therapeutics (ONCT) United States $0.213B 0.00
Taiwan Liposome (TLC) Taiwan $0.192B 0.00
IsoRay (ISR) United States $0.192B 0.00
Novan (NOVN) United States $0.191B 0.00
Aquestive Therapeutics (AQST) United States $0.190B 0.00
Oasmia Pharmaceutical AB (OASMY) Sweden $0.188B 0.00
Ayala Pharmaceuticals (AYLA) Israel $0.184B 0.00
Heat Biologics (HTBX) United States $0.183B 0.00
ProPhase Labs (PRPH) United States $0.182B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.170B 0.00
Champions Oncology (CSBR) United States $0.162B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.155B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.155B 0.00
ALLERGY THERAPT (AGYTF) United Kingdom $0.153B 0.00
Lipocine (LPCN) United States $0.145B 0.00
Onconova Therapeutics (ONTX) United States $0.142B 0.00
MediWound (MDWD) Israel $0.139B 0.00
ElectroCore (ECOR) United States $0.125B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.122B 0.00
Aptorum Group (APM) Hong Kong, SAR China $0.116B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.098B 0.00
Nutriband (NTRB) United States $0.092B 0.00
Iterum Therapeutics (ITRM) Ireland $0.089B 0.00
Hemispherx BioPharma (AIM) United States $0.089B 0.00
Biomerica (BMRA) United States $0.088B 0.00
KemPharm (KMPH) United States $0.088B 0.00
Natural Alternatives (NAII) United States $0.086B 165.37
SCYNEXIS (SCYX) United States $0.084B 0.00
Recro Pharma (REPH) United States $0.083B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.081B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.074B 0.00
AgeX Therapeutics (AGE) United States $0.073B 0.00
Vical (BBI) United States $0.069B 0.00
CV Sciences (CVSI) United States $0.066B 0.00
India Globalization Capital (IGC) United States $0.064B 0.00
Addex Therapeutics (ADXN) Switzerland $0.064B 0.00
PolarityTE (PTE) United States $0.061B 0.00
Trimel Pharmaceuticals (ASPCF) Canada $0.057B 0.00
RENEURON GP (RNUGF) United Kingdom $0.057B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.053B 0.00
Regulus Therapeutics (RGLS) United States $0.050B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.050B 25.39
Neos Therapeutics (NEOS) United States $0.044B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.043B 0.00
NovaBay Pharmaceuticals (NBY) United States $0.040B 0.00
Mannatechorporated (MTEX) United States $0.040B 5.88
Can-Fite Biopharma (CANF) Israel $0.032B 0.00
Midatech Pharma (MTP) United Kingdom $0.031B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.031B 0.00
Flex Pharma (SLRX) United States $0.031B 0.00
China SXT Pharmaceuticals (SXTC) China $0.022B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.022B 0.00
Cyanotech (CYAN) United States $0.021B 33.95
HANCOCK JAFFE (HJLI) United States $0.020B 0.00
Xenetic Biosciences (XBIO) United States $0.017B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.017B 0.00
RXi Pharmaceuticals (PHIO) United States $0.017B 0.00
Cytori Therapeutics Inc (PSTV) United States $0.015B 0.00
SHINECO INC (TYHT) China $0.011B 0.00
JanOne (JAN) United States $0.010B 0.00
CannTrust Holdings (CTST) Canada $0.000B 0.00